NasdaqGM:ALVO 1 Year Share Price vs Fair Value Explore Alvotech's Fair Values from the Community and select ...

In terms of operating cash flow, Q2 2025 is the strongest quarter in the history of Alvotech and demonstrates the strength of our core business operations, which is reflected in high product revenue ...

Strong performance driven by over 200% growth in product revenues year-on-year Best quarter in Alvotech’s history in terms of operating cash flows Continued expansion of commercial partnerships for ...

Discover key takeaways from Alvotech's Q2 2025 earnings call, including 200% revenue growth, market share gains, R&D expansions & strategic acquisitions.

Alvotech (ALVO) delivered earnings and revenue surprises of +153.85% and +50.56%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Alvotech ( (ALVO) ) has released its Q2 earnings. Here is a breakdown of the information Alvotech presented to its investors.Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% ...

The average of price targets set by Wall Street analysts indicates a potential upside of 102.3% in Alvotech (ALVO). While the effectiveness of this highly sought-after metric is questionable, the ...

Analysts expect Alvotech to report an earnings per share (EPS) of $-0.11. The announcement from Alvotech is eagerly anticipated, with investors seeking news of surpassing estimates and favorable ...

Alvotech (NASDAQ: ALVO), a global biotech company specialized in the development and manufacture of biosimilar medicines for patients worldwide, announced today that ...

Alvotech ( ($ALVO) ) just unveiled an update. Alvotech reported financial results for the first half of 2025, showing a significant increase in ...

On June 26, 2025, Formycon AG (“Formycon”) announced a distribution agreement with Teva Group subsidiary Ratiopharm GmbH (“Ratiopharm”) for ...

Autostore Holdings Ltd. was the biggest leader among large stocks during the session, soaring 29.8%, and Torm PLC jumped 10.3%. H. Lundbeck A/S Cl A rounded out the top three leaders on Thursday, with ...